Creative Commons source reading · Brain aging and cognitive reserve
Type 2 diabetes mellitus accelerates brain aging and cognitive decline: Complementary findings from UK Biobank and meta-analyses.
Botond Antal; Liam P McMahon; Syed Fahad Sultan; Andrew Lithen; Deborah J Wexler; Bradford Dickerson; Eva-Maria Ratai; Lilianne R Mujica-Parodi
Originally published in eLife · 2022-05-24
From the article
Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.
Abstract
Background Type 2 diabetes mellitus (T2DM) is known to be associated with neurobiological and cognitive deficits; however, their extent, overlap with aging effects, and the effectiveness of existing treatments in the context of the brain are currently unknown. Methods We characterized neurocognitive effects independently associated with T2DM and age in a large cohort of human subjects from the UK Biobank with cross-sectional neuroimaging and cognitive data. We then proceeded to evaluate the extent of overlap between the effects related to T2DM and age by applying correlation measures to the separately characterized neurocognitive changes. Our findings were complemented by meta-analyses of published reports with cognitive or neuroimaging measures for T2DM and healthy controls (HCs). We also evaluated in a cohort of T2DM-diagnosed individuals using UK Biobank how disease chronicity and metformin treatment interact with the identified neurocognitive effects. Results The UK Biobank dataset included cognitive and neuroimaging data (N = 20,314), including 1012 T2DM and 19,302 HCs, aged between 50 and 80 years.
Discussion
The UK Biobank dataset confirms that T2DM patients show deficits in cognitive performance compared to HC, even after controlling for age, sex, education, and hypertension. These findings were supported by meta-analysis of the published literature. Deficits in cognitive performance were accompanied by marked brain atrophy in the T2DM sample compared to age-matched HC. The atrophy was most severe (6.2% gray matter loss compared to HC) in the ventral striatum, a region critical to learning, decision-making, goal-directed behavior, and cognitive control.
Editorial reading guide
- Was the evidence cross-sectional, longitudinal or experimental?
- How did the authors account for age, disease stage and differences among participants?
